Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Medifast, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

BALTIMORE--(BUSINESS WIRE)--MEDIFAST (NYSE: MED), THE METABOLIC HEALTH AND WELLNESS COMPANY KNOWN FOR ITS SCIENCE-BACKED COMPREHENSIVE METABOLIC HEALTH SYSTEM, TRILIVY, WILL ANNOUNCE FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 ON MONDAY, AUGUST 3, 2026, AFTER MARKET CLOSE. THE COMPANY WILL HOST A CONFERENCE CALL TO DISCUSS THE RESULTS WITH ADDITIONAL COMMENTS AND DETAILS. COMPANY PARTICIPANTS WILL BE NICK JOHNSON, CHIEF EXECUTIVE OFFICER, AND JIM MALONEY, CHIEF FINANCIAL OFFICER. THE.

MEDIFAST TO ANNOUNCE FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2026

BALTIMORE--(BUSINESS WIRE)--MEDIFAST, INC. (NYSE: MED) TODAY ANNOUNCED THE LAUNCH OF TRILIVY, A COMPREHENSIVE METABOLIC HEALTH SYSTEM UNIQUELY DESIGNED TO SUPPORT HEALTHY LIFESTYLE CHANGE. THE LAUNCH ALSO INTRODUCES NEWLY FORMULATED MEAL REPLACEMENTS, INCLUDING THE TRILIVY RESET FUELING LINE ENHANCED WITH METAVANTAGE TECHNOLOGY, A PLATFORM OF PROPRIETARY INGREDIENT FORMULAS INTENDED TO OPTIMIZE METABOLISM BY UNLOCKING KEY METABOLIC PATHWAYS. THE LAUNCH OF TRILIVY MARKS A MAJOR CORPORATE TRANSF.

MEDIFAST ENTERS A NEW ERA: INTRODUCING TRILIVY, A SCIENCE-BACKED METABOLIC HEALTH SYSTEM

THE WEIGHT LOSS AND WEIGHT MANAGEMENT MARKET WAS VALUED AT $31.07 BILLION IN 2025 A PROGRAM CAN DESCRIBE ITS RESULTS AS CLINICALLY MEANINGFUL WITHOUT SPECIFYING WHAT WAS MEASURED, HOW IT WAS MEASURED, OR WHETHER THE MEASUREMENT TOOL WAS CAPABLE OF CAPTURING THE OUTCOME BEING CLAIMED DXA SCANNING DISTINGUISHES FAT MASS, LEAN MASS, AND BONE MINERAL CONTENT WITH GREATER PRECISION THAN BMI CALCULATIONS AND JUST WEIGHT NUMBER ON A SCALE STUDY COMPLETION RATES CARRY SIGNIFICANT WEIGHT IN HOW RESEARCH FINDINGS SHOULD BE INTERPRETED BALTIMORE, MD, JUNE 11, 2026 (GLOBE NEWSWIRE) -- SUBSCRIPTION HEALTH PROGRAMS COMPETE ON OUTCOME LANGUAGE AS MUCH AS THEY COMPETE ON RESULTS. TERMS LIKE "CLINICALLY STUDIED," "SCIENCE-BACKED," "PROVEN," AND "EVIDENCE-BASED" APPEAR ACROSS A WIDE SPECTRUM OF PROGRAMS, FROM PROGRAMS WITH PUBLISHED RANDOMIZED CONTROLLED TRIALS TO THOSE WITH INGREDIENT-LEVEL PILOT DATA.

WHAT SCIENCE-BACKED SUBSCRIPTION HEALTH PROGRAMS MEASURE DIFFERENTLY

OPTAVIA'S CLINICAL PROGRAM REDUCES VISCERAL FAT 14% AND RETAINS 98% LEAN MASS, DIRECTLY ADDRESSING THE METABOLIC IMPACT OF PERIMENOPAUSE AND MENOPAUSE.

METABOLIC HEALTH AFTER 40: WHAT PERIMENOPAUSE AND MENOPAUSE MEAN FOR WEIGHT MANAGEMENT

BALTIMORE--(BUSINESS WIRE)--MEDIFAST, INC. (NYSE: MED) TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS FORMALLY APPOINTED NICHOLAS JOHNSON AS CHIEF EXECUTIVE OFFICER, EFFECTIVE JUNE 1, 2026. JOHNSON WILL SUCCEED DAN CHARD AS CEO, WHO WILL CONTINUE TO SERVE AS CHAIRMAN OF THE BOARD. THE APPOINTMENT FOLLOWS THE LEADERSHIP TRANSITION PLAN THAT THE COMPANY DISCLOSED IN JANUARY AND REFLECTS THE BOARD'S CONFIDENCE IN JOHNSON'S LEADERSHIP AND THE COMPANY'S STRATEGIC DIRECTION. CHARD WILL REMAIN ACTIVE.

MEDIFAST CONFIRMS APPOINTMENT OF NICHOLAS JOHNSON AS CHIEF EXECUTIVE OFFICER

A RANDOMIZED CONTROLLED TRIAL PUBLISHED IN OBESITY SCIENCE & PRACTICE FOUND THAT CLIENTS ON THE OPTAVIA OPTIMAL WEIGHT 5 & 1 PLAN WHO WORKED WITH A COACH LOST SIGNIFICANTLY MORE WEIGHT AND FAT THAN THOSE WHO ATTEMPTED THE PROGRAM WITHOUT COACHING SUPPORT (ARTERBURN LM, ET AL., 2019) HIGHER RETENTION IN A WEIGHT MANAGEMENT PROGRAM IS DIRECTLY CORRELATED WITH MORE SIGNIFICANT WEIGHT LOSS OUTCOMES, PER A 2024 SYSTEMATIC REVIEW AND META-ANALYSIS OPTAVIA COACHES COMPLETE A PROGRAM-SPECIFIC EDUCATION CURRICULUM AND MUST PASS A CERTIFICATION EXAM BEFORE SUPPORTING PARTICIPANTS INDEPENDENT RESEARCH COMMISSIONED BYOPTAVIA FOUND THAT 96% OF AMERICANS RECOGNIZE LIFESTYLE CHANGES ARE ESSENTIAL FOR WEIGHT LOSS AND MANAGEMENT, YET ONLY 17% FEEL CONFIDENT THEY CAN MANAGE IT ALONE BALTIMORE, MD, MAY 21, 2026 (GLOBE NEWSWIRE) -- OPTAVIA, A SCIENCE-BACKED, COACH-GUIDED COMPREHENSIVE METABOLIC HEALTH SYSTEM, IS BUILT AROUND A CORE PRINCIPLE: THAT STRUCTURED HUMAN SUPPORT CHANGES OUTCOMES.

THE HUMAN LAYER IN WEIGHT MANAGEMENT: WHAT OPTAVIA'S COACHING MODEL IS BUILT TO DO

70% OF USERS DISCONTINUED USE OF LIFESTYLE BEHAVIOR AND HEALTH APPS WITHIN THE FIRST 100 DAYS (KIDMAN PG, ET AL., 2024) EARLY WEIGHT LOSS AT WEEK FOUR IS A STRONG PREDICTOR OF CLINICALLY RELEVANT OUTCOMES, WITH RESEARCH IDENTIFYING ADDITIONAL COUNSELING AND SUPPORT AS KEY FOR THOSE SHOWING LOWER EARLY PROGRESS (COLEMAN CD, ET AL.

WEIGHT LOSS COACHING VS. APP-ONLY PROGRAMS: WHAT PUBLISHED RESEARCH SHOWS ABOUT LONG-TERM OUTCOMES

BODY COMPOSITION, SPECIFICALLY VISCERAL FAT LEVELS AND LEAN MASS, PLAYS A MEANINGFUL ROLE IN LONG-TERM METABOLIC HEALTH (SERRA MC, ET AL., 2019) STRUCTURED PLANS, HABIT BUILDING, AND DEDICATED COACH SUPPORT WORK TOGETHER TO PRODUCE BODY COMPOSITION OUTCOMES THAT REFLECT THE QUALITY OF WEIGHT LOSS, NOT JUST ITS QUANTITY (ARTERBURN LM, ET AL.

PEER-REVIEWED RESEARCH SHOWS STRUCTURED MEAL REPLACEMENT PROGRAMS SUPPORT VISCERAL FAT REDUCTION AND LEAN MASS PRESERVATION

THE GLOBAL WEIGHT LOSS INDUSTRY WAS VALUED AT $16.3 BILLION IN 2025, YET PEER-REVIEWED CLINICAL VALIDATION OF PROGRAM OUTCOMES REMAINS UNEVEN ACROSS THE CATEGORY RANDOMIZED CONTROLLED TRIALS CONTROL FOR THE LIFESTYLE VARIABLES AND SELECTION BIAS THAT SELF-REPORTED PROGRAM DATA CANNOT ACCOUNT FOR, MAKING THEM THE STANDARD FOR EVALUATING WHETHER A WEIGHT LOSS PROGRAM ITSELF IS DRIVING OUTCOMES BODY COMPOSITION IS THE BREAKDOWN OF FAT, LEAN MASS, AND BONE. IT SHOWS WHAT WEIGHT LOSS IS ACTUALLY MADE UP OF, A DISTINCTION THAT SCALE WEIGHT ALONE CANNOT CAPTURE A COACH CAN ADDRESS THE SPECIFIC BARRIERS THAT MAY CAUSE PROGRAM ADHERENCE TO STALL, PROVIDING AN ADDITIONAL SUPPORT COMPARED TO DIGITAL TRACKERS AND TOOLS BALTIMORE, MD, MAY 15, 2026 (GLOBE NEWSWIRE) -- CLIENT EXPERIENCES AND PEER-REVIEWED RESEARCH ARE TWO PILLARS OF EVIDENCE THAT, AT THEIR BEST, REINFORCE EACH OTHER.

PEER-REVIEWED RESEARCH IS REDEFINING WEIGHT LOSS PROGRAM STANDARDS

BALTIMORE--(BUSINESS WIRE)--MEDIFAST (NYSE: MED), THE METABOLIC HEALTH AND WELLNESS COMPANY KNOWN FOR ITS SCIENCE-BACKED, COACH-GUIDED LIFESTYLE SYSTEM, TODAY REPORTED RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026. FIRST QUARTER 2026 REVENUE OF $76.0 MILLION, WITH REVENUE PER ACTIVE EARNING COACH OF $5,432 INDEPENDENT ACTIVE EARNING COACHES OF 14,000 NET LOSS OF $2.1 MILLION, OR $0.19 PER DILUTED SHARE ("EPS") CASH, CASH EQUIVALENTS, AND INVESTMENT SECURITIES OF $168.9 MILLION WITH NO DEBT.

Medifast, Inc.

MED

Price

Financial Reports

No items found.

Press Releases

Medifast, Inc.

MED.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

MED